Sadatsune Eduardo Jun, Leal Plínio da Cunha, Cossetti Rachel Jorge Dino, Sakata Rioko Kimiko
MD, MSc. Anesthesist, Department of Surgery, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil.
MD, PhD. Professor, Department of Medicine I, Universidade Federal do Maranhão (UFMA), São Luís, MA, Brazil.
Sao Paulo Med J. 2016 Jul-Sep;134(4):285-91. doi: 10.1590/1516-3180.2015.00980710. Epub 2016 Mar 18.
Effective postoperative analgesia is important for reducing the incidence of chronic pain. This study evaluated the effect of preoperative gabapentin on postoperative analgesia and the incidence of chronic pain among patients undergoing carpal tunnel syndrome surgical treatment.
Randomized, double-blind controlled trial, Federal University of São Paulo Pain Clinic.
Forty patients aged 18 years or over were randomized into two groups: Gabapentin Group received 600 mg of gabapentin preoperatively, one hour prior to surgery, and Control Group received placebo. All the patients received intravenous regional anesthesia comprising 1% lidocaine. Midazolam was used for sedation if needed. Paracetamol was administered for postoperative analgesia as needed. Codeine was used additionally if the paracetamol was insufficient. The following were evaluated: postoperative pain intensity (over a six-month period), incidence of postoperative neuropathic pain (over a six-month period), need for intraoperative sedation, and use of postoperative paracetamol and codeine. The presence of neuropathic pain was established using the DN4 (Douleur Neuropathique 4) questionnaire. Complex regional pain syndrome was diagnosed using the Budapest questionnaire.
No differences in the need for sedation, control over postoperative pain or incidence of chronic pain syndromes (neuropathic or complex regional pain syndrome) were observed. No differences in postoperative paracetamol and codeine consumption were observed.
Preoperative gabapentin (600 mg) did not improve postoperative pain control, and did not reduce the incidence of chronic pain among patients undergoing carpal tunnel syndrome surgery.
有效的术后镇痛对于降低慢性疼痛的发生率至关重要。本研究评估了术前加巴喷丁对接受腕管综合征手术治疗患者术后镇痛及慢性疼痛发生率的影响。
随机、双盲对照试验,圣保罗联邦大学疼痛诊所。
40例18岁及以上患者随机分为两组:加巴喷丁组在术前1小时手术前接受600mg加巴喷丁,对照组接受安慰剂。所有患者均接受包含1%利多卡因的静脉区域麻醉。必要时使用咪达唑仑镇静。根据需要给予对乙酰氨基酚用于术后镇痛。若对乙酰氨基酚效果不佳则额外使用可待因。评估以下指标:术后疼痛强度(为期6个月)、术后神经性疼痛发生率(为期6个月)、术中镇静需求以及术后对乙酰氨基酚和可待因的使用情况。使用DN4(神经病理性疼痛4)问卷确定是否存在神经性疼痛。使用布达佩斯问卷诊断复杂性区域疼痛综合征。
在镇静需求、术后疼痛控制或慢性疼痛综合征(神经性或复杂性区域疼痛综合征)发生率方面未观察到差异。术后对乙酰氨基酚和可待因的消耗量也未观察到差异。
术前加巴喷丁(600mg)并未改善接受腕管综合征手术患者的术后疼痛控制,也未降低慢性疼痛的发生率。